The purpose of this study is to assess the clinical efficacy and safety of 100 milligram subcutaneous mepolizumab as an add-on to maintenance treatment in adults with severe bilateral nasal polyps.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.